Cardiogen dosage and evidence

Cardiogen is a lab-made peptide from Russian research, aimed at the heart and blood vessels as they age.

Cardiogen is a lab-made peptide four building blocks long. In Khavinson's system it is a 'bioregulator' aimed at the heart and blood vessels. It is studied for keeping them working with age. Both of its sources here are reviews from that same group, not studies of the peptide. A 2002 review sets out the bioregulator idea but does not show Cardiogen works. A 2022 review argues the peptide controls molecules tied to ageing heart and blood vessel cells. That is an argument about how it might work, not proof that it does. It is not approved.

One fact about this whole family of peptides is worth saying plainly. You can check it in about a minute, and almost nobody mentions it. Search the ClinicalTrials.gov registry for epitalon, epithalamin, thymalin, pancragen, cortexin, endoluten, vladonix, or Khavinson himself. Every search returns zero registered studies. So the human claims rest on work nobody registered in advance. That means you cannot check what was measured against what was planned before the results came in. Most of the work also comes from one research group tied to the institute that sells these products. The study summaries do not report side effects in any regular way. So the quiet safety record means side effects were not reported. It does not mean these products are safe. Our own check has a limit. ClinicalTrials.gov is a US registry. These are Russian products, and we did not search a Russian registry or the WHO's world registry. So this shows they are missing from the registry most researchers use, not from every registry there is.